Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Kenderick Lee was 24 and carving out a successful career in the corporate world when a diagnosis of the skin disease ...

Based on the immunopathology of psoriasis, we have proposed a model for biologic therapeutic approaches that identifies four mechanistic strategies. [25] A host of targeted immunologic ...

Fungal infections are more common in patients with psoriasis who receive interleukin-17 inhibitors, are of older age at the time of biologic therapy initiation, and have diabetes. Patients with ...

Treatment persistence varied by biologic therapy use, sex, and diagnostic codes among patients with psoriasis.

PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new ...

The approvals add two more options for psoriasis patients hoping to stay away from biologics as long as they can. If symptoms remain mild to moderate, patients can stay on these drugs indefinitely.

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

At one point BMS was pitching its TYK2 drug as offering efficacy in line with injectable biologic drugs for psoriasis, but with the convenience of oral dosing, although the final readouts from its ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the ...

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms ...